Myriad Genetics, Inc. Provides Financial Guidance for 2023 and 2024
Myriad Genetics introduces its 2024 revenue guidance of between $815 million and $835 million, or 9% - 11% growth over the mid-point of the 2023 revenue guidance range.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.9 USD | -0.54% |
|
+1.44% | +24.87% |
1st Jan change | Capi. | |
---|---|---|
+24.87% | 2.16B | |
-10.54% | 11.41B | |
-11.02% | 7.53B | |
+30.85% | 5.62B | |
-16.28% | 3.82B | |
+8.39% | 2.6B | |
-64.67% | 2.37B | |
-9.76% | 2.26B | |
-12.06% | 1.71B | |
-7.26% | 1.43B |